ThinkEquity says that its channel checks show the spine market remains stable despite the...

|By:, SA News Editor

ThinkEquity says that its channel checks show the spine market remains stable despite the challenging environment, and that Nuvasive (NUVA -0.7%) is poised to beat Q2 Street estimates. The firm ups its price target to $30 from $25 and reiterates a Buy.